<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Microcirculatory disturbances contribute to the expansion of <z:mpath ids='MPATH_124'>infarct</z:mpath> lesions after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, it was shown that Rho-kinase involves in <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> via down-regulation of endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase function in a rodent <z:hpo ids='HP_0001297'>stroke</z:hpo> model </plain></SENT>
<SENT sid="2" pm="."><plain>However, it is not clear whether endothelial Rho-kinase is activated in vivo or Rho-kinase activation contributes to microcirculatory disturbances after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we assessed the temporal and spatial profiles of Rho-kianse activity and the effect of the Rho-kinase inhibitor fasudil on microcirculatory disturbances in the focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Rho-kinase activation was evaluated by analyzing the phosphorylation of adducin, a substrate of Rho-kinase, by immunohistochemistry </plain></SENT>
<SENT sid="5" pm="."><plain>Staining for p-adducin was found in endothelia in the ischemic area 6 hr after induction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Microcirculatory disturbances and increased endothelial cell staining for <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (vWF) were observed in the same area </plain></SENT>
<SENT sid="7" pm="."><plain>Postischemic treatment with fasudil suppressed endothelial Rho-kinase activation, preserved microcirculation, and inhibited endothelial cell vWF staining </plain></SENT>
<SENT sid="8" pm="."><plain>These effects resulted in inhibition of <z:mpath ids='MPATH_124'>infarct</z:mpath> expansion and improvement of neurologic deficits </plain></SENT>
<SENT sid="9" pm="."><plain>These findings indicate that Rho-kinase is activated in the endothelial cells and contributes to microcirculatory disturbances in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>The vascular protective effect of Rho-kinase inhibitors may be useful in the treatment of the <z:hpo ids='HP_0011009'>acute</z:hpo> phase of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>